AT

Alasdair Thong

Biotechnology/Deeptech/Healthcare

London, England

Invests in

Locations:

  • Min Investment:

    $250,000.00
  • Max Investment:

    $1,000,000.00
  • Target Investment:

    $500,000.00

Skills

Strategy
Entrepreneurship
Start-ups
Business Development
French
Research
Social Media Marketing
Marketing Strategy
Event Planning
Business Strategy
Venture Capital
Private Equity
Valuation
Management
Contract Law
Drug Development
Biotechnology
Pharmaceutical Industry
Due Diligence

Education

Work Experience

  • Founding Partner

    2019

    Selvedge Venture is a Venture Capital management and advisory firm with a focus on deep tech in life sciences and healthcare. https://selvedgeventure.com

  • Co-Founder and Non-Executive Director

    2021

    Multiomic Health is a next-generation precision medicine venture, integrating computational systems biology with laboratory science to develop and commercialize new therapeutics for metabolic syndrome — the world’s largest healthcare burden. https://multiomic.health

  • Venture Partner

    2020

    Mubadala Capital is the wholly owned asset management arm of Mubadala Investment Company with over USD$16 billion AUM. Mubadala is an Abu Dhabi sovereign wealth investor with USD$250bn+ AUM. https://www.mubadala.com/en/what-we-do/capital/ventures

  • Venture Partner: Healthcare

    2020

    Ada Ventures is the inclusive venture firm. Ada Ventures finds and funds extraordinary talent building breakthrough ideas for the hardest problems we face. We are investing out of our second fund and we invest £250,000 - £1m in UK technology companies across climate, economic empowerment and healthcare & ageing. If you are raising seed capital for your start-up you can apply directly below: Fundraising: https://adaventures.typeform.com/AdaSubmissions https://www.adaventures.com/

  • Acquisitions and Investments (Advisory)

    2024

    The Ellison Institute of Technology’s mission is to develop and deploy technology in pursuit of solving some of humanity’s most challenging and enduring problems. Guided by world leaders, scientists and entrepreneurs, EIT seeks to accelerate innovation in health and medical science, food security and sustainable agriculture, climate change and clean energy, and government innovation and era of artificial intelligence. https://eit.org

  • Consultant (Advisory)

    2023

    Biotechnology development government advisory work to help build nascent and emerging bio-economies. https://www.institute.global

2023

  • Investor

    2023

    via Mubadala Capital

  • Board Observer

    2021

  • Investor/Advisor

    2021

  • Investor/Advisor

    2021